Connexin 43-enriched small extracellular vesicles
Connexin 43-enriched small extracellular vesicles has been studied in 1 paper since 2022: none in people yet, 1 in cells. No study of it in people or animals has been published yet. The newest paper, Aug 5, 2022: “Extracellular vesicles enriched in connexin 43 promote a senescent phenotype in bone and synovial cells contributing to osteoarthritis progression”.
1 paper studies it1 findingUpdated
- 1 lab in 1 country
- Funders: EuroNanoMed III and 3 more
- Cells1
What did studies of Connexin 43-enriched small extracellular vesicles find?
1Studies of Connexin 43-enriched small extracellular vesicles measured 1 outcome; the most studied are inflammation (1 study).
Inflammation
upin human cells1
1 study
Inflammation
upin human cells1
Connexin 43-enriched small extracellular vesicles induce inflammation in human cells.
“Cx43-sEVs released by OA-derived chondrocytes spread senescence, inflammation and reprogramming factors involved in wound healing failure to neighbouring tissues”
Cellsreleased by OA-derived chondrocytes
Cell death & disease